| Characteristic | Number of COVID-19 vaccine doses received | Overall N = 6041 | p-value2 | ||
| 0 N = 5041 | 1 N = 451 | 2 N = 551 | |||
| Age (Year) | 56 (41 - 68) | 48 (38 - 59) | 55 (44 - 65) | 54 (41 - 68) | 0.074 |
| Age classes (Year) |
|
|
|
| - |
| <20 | 6 (1.2) | 0 (0.0) | 0 (0.0) | 6 (1.0) |
|
| 20 - 39 | 99 (19.6) | 12 (26.7) | 11 (20.0) | 122 (20.2) |
|
| 40 - 59 | 180 (35.7) | 22 (48.9) | 24 (43.6) | 226 (37.4) |
|
| 60 - 79 | 182 (36.1) | 8 (17.8) | 18 (32.7) | 208 (34.4) |
|
| ≥80 | 37 (7.3) | 3 (6.7) | 2 (3.6) | 42 (7.0) |
|
| Age (Year) |
|
|
|
| 0.138 |
| <55 | 247 (49.0) | 29 (64.4) | 27 (49.1) | 303 (50.2) |
|
| ≥55 | 257 (51.0) | 16 (35.6) | 28 (50.9) | 301 (49.8) |
|
| Sex |
|
|
|
| 0.006 |
| Female | 255 (50.6) | 29 (64.4) | 18 (32.7) | 302 (50.0) |
|
| Male | 249 (49.4) | 16 (35.6) | 37 (67.3) | 302 (50.0) |
|
| Nationality |
|
|
|
| 0.342 |
| Other | 26 (5.2) | 1 (2.2) | 5 (9.1) | 32 (5.3) |
|
| Togolese | 478 (94.8) | 44 (97.8) | 50 (90.9) | 572 (94.7) |
|
| Clinical severity at admission |
|
|
|
| <0.001 |
| Asymptomatic/Mild | 92 (18.3) | 11 (24.4) | 24 (43.6) | 127 (21.0) |
|
| Moderate | 128 (25.4) | 14 (31.1) | 14 (25.5) | 156 (25.8) |
|
| Severe | 215 (42.7) | 16 (35.6) | 17 (30.9) | 248 (41.1) |
|
| Critical | 69 (13.7) | 4 (8.9) | 0 (0.0) | 73 (12.1) |
|
| Evolution |
|
|
|
| 0.003 |
| Dead | 155 (30.8) | 12 (26.7) | 5 (9.1) | 172 (28.5) |
|
| Healed/Alive | 349 (69.2) | 33 (73.3) | 50 (90.9) | 432 (71.5) |
|
| Hospitalization in intensive care | 326 (64.7) | 20 (44.4) | 21 (38.2) | 367 (60.8) | <0.001 |
| At least one complication | 58 (11.5) | 1 (2.2) | 7 (12.7) | 66 (10.9) | 0.120 |
| Hospitalization duration | 10 (6 - 16) | 9 (8 - 13) | 10 (8 - 14) | 10 (6 - 15) | 0.602 |